Mark Tremelling
-
- Immunodeficiency and Autoimmune Disorders 2
- IL-33, ST2, and ILC Pathways 2
- Genetics top 10%
- Inflammatory Bowel Disease 14
-
- Helicobacter pylori-related gastroenterology studies 7
- Eosinophilic Esophagitis 2
-
- Microscopic Colitis 4
-
- Whipple's Disease and Interleukins 2
-
- Spondyloarthritis Studies and Treatments 2
- Co-authors
- Miles ParkesFrancesca BredinDunecan MasseyHu ZhangCarlo BerzuiniSheila BinghamSarah WallerSimon Greenfield
- Cited by
- ImmunologyGeneticsGastroenterology
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Mark Tremelling
18 papers receiving 374 citations
Peers
Comparison fields: 5 of 57
- Immunology 180
- Genetics 182
- Gastroenterology 23
- Hematology 40
- Infectious Diseases 52
Countries citing papers authored by Mark Tremelling
This map shows the geographic impact of Mark Tremelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tremelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tremelling more than expected).
Fields of papers citing papers by Mark Tremelling
This network shows the impact of papers produced by Mark Tremelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tremelling. The network helps show where Mark Tremelling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Tremelling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 16 | |
| 2 | 2022 | 6 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 1 | |
| 5 | 2019 | 0 | |
| 6 | 2018 | 38 | |
| 7 | 2014 | 3 | |
| 8 | 2012 | 0 | |
| 9 | 2012 | 27 | |
| 10 | 2011 | 2 | |
| 11 | 2010 | 53 | |
| 12 | 2008 | 44 | |
| 13 | 2008 | 59 | |
| 14 | The pharmacogenetics of folate and purine metabolic pathways in methotrexate therapy of inflammatory bowel disease. | 2007 | 1 |
| 15 | HLA-G 14BP insertion-deletion polymorphism influences response to methotrexate in inflammatory bowel disease. | 2007 | 1 |
| 16 | 2007 | 12 | |
| 17 | 2007 | 20 | |
| 18 | 2007 | 1 | |
| 19 | 2006 | 39 | |
| 20 | 2006 | 25 |
About Mark Tremelling
Mark Tremelling is a scholar working on Genetics, Immunology and Rheumatology, having authored 20 papers that have together received 380 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (14 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Microscopic Colitis (4 papers), Eosinophilic Esophagitis (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Whipple's Disease and Interleukins (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). The work is most often cited by research in Immunology (180 citations), Genetics (182 citations) and Gastroenterology (23 citations). Mark Tremelling has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Miles Parkes, Francesca Bredin, Dunecan Massey, Hu Zhang, Carlo Berzuini, Sheila Bingham, Sarah Waller, Simon Greenfield, Gregory J. Lewis and C.J. Price. Their work appears in journals such as Inflammatory Bowel Diseases, Gut, Gastroenterology, Nature Communications and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.